Innate and adaptive immune responses in subjects with CPA secondary to post‐pulmonary tuberculosis lung abnormalities

Background Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood. Methods...

Full description

Saved in:
Bibliographic Details
Published inMycoses Vol. 67; no. 5; pp. e13746 - n/a
Main Authors Chirumamilla, Naresh Kumar, Arora, Kanika, Kaur, Mandeep, Agarwal, Ritesh, Muthu, Valliappan, Rawat, Amit, Dhooria, Sahajal, Prasad, Kuruswamy Thurai, Aggarwal, Ashutosh Nath, Rudramurthy, Shivaprakash M., Chakrabarti, Arunaloke, Choudhary, Hansraj, Pal, Arnab, Sehgal, Inderpaul Singh
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood. Methods We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose‐binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA. Results We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th‐1 immune response (lower Th‐1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B‐cell subsets and other T lymphocyte subsets. Conclusion Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th‐1 response than controls.
AbstractList Post-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood. We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose-binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA. We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th-1 immune response (lower Th-1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B-cell subsets and other T lymphocyte subsets. Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th-1 response than controls.
BackgroundPost‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.MethodsWe prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose‐binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.ResultsWe included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th‐1 immune response (lower Th‐1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B‐cell subsets and other T lymphocyte subsets.ConclusionSubjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th‐1 response than controls.
Post-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.BACKGROUNDPost-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose-binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.METHODSWe prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose-binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th-1 immune response (lower Th-1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B-cell subsets and other T lymphocyte subsets.RESULTSWe included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th-1 immune response (lower Th-1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B-cell subsets and other T lymphocyte subsets.Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th-1 response than controls.CONCLUSIONSubjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th-1 response than controls.
Background Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood. Methods We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose‐binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA. Results We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th‐1 immune response (lower Th‐1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B‐cell subsets and other T lymphocyte subsets. Conclusion Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th‐1 response than controls.
Author Dhooria, Sahajal
Chakrabarti, Arunaloke
Arora, Kanika
Muthu, Valliappan
Rawat, Amit
Kaur, Mandeep
Agarwal, Ritesh
Rudramurthy, Shivaprakash M.
Chirumamilla, Naresh Kumar
Sehgal, Inderpaul Singh
Aggarwal, Ashutosh Nath
Prasad, Kuruswamy Thurai
Choudhary, Hansraj
Pal, Arnab
Author_xml – sequence: 1
  givenname: Naresh Kumar
  surname: Chirumamilla
  fullname: Chirumamilla, Naresh Kumar
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 2
  givenname: Kanika
  surname: Arora
  fullname: Arora, Kanika
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 3
  givenname: Mandeep
  surname: Kaur
  fullname: Kaur, Mandeep
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 4
  givenname: Ritesh
  orcidid: 0000-0003-2547-7668
  surname: Agarwal
  fullname: Agarwal, Ritesh
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 5
  givenname: Valliappan
  orcidid: 0000-0003-0410-8468
  surname: Muthu
  fullname: Muthu, Valliappan
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 6
  givenname: Amit
  surname: Rawat
  fullname: Rawat, Amit
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 7
  givenname: Sahajal
  surname: Dhooria
  fullname: Dhooria, Sahajal
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 8
  givenname: Kuruswamy Thurai
  surname: Prasad
  fullname: Prasad, Kuruswamy Thurai
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 9
  givenname: Ashutosh Nath
  surname: Aggarwal
  fullname: Aggarwal, Ashutosh Nath
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 10
  givenname: Shivaprakash M.
  orcidid: 0000-0002-9097-9253
  surname: Rudramurthy
  fullname: Rudramurthy, Shivaprakash M.
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 11
  givenname: Arunaloke
  surname: Chakrabarti
  fullname: Chakrabarti, Arunaloke
  organization: Doodhadhari Burfani Hospital
– sequence: 12
  givenname: Hansraj
  surname: Choudhary
  fullname: Choudhary, Hansraj
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 13
  givenname: Arnab
  orcidid: 0000-0002-0850-3118
  surname: Pal
  fullname: Pal, Arnab
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 14
  givenname: Inderpaul Singh
  orcidid: 0000-0002-6505-6019
  surname: Sehgal
  fullname: Sehgal, Inderpaul Singh
  email: inderpgi@outlook.com
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38767275$$D View this record in MEDLINE/PubMed
BookMark eNp10c1u1DAQB3ALFdFt4cALIEtc4JDWjhN_HKsVH5WK4AAHTpEdT8CrxA6ZuKu98Qg8I0-C6RYOSPgykvXzaMb_M3ISUwRCnnJ2wcu5nA79BReqkQ_IhjfCVKxl6oRsmBGiUg1Tp-QMcccYV6aWj8ip0EqqWrUbsr-O0a5AbfTUejuv4RZomKYcgS6Ac4oISEOkmN0O-hXpPqxf6fbDFUXoU_R2OdA10Tnh-vP7jzmPU4p3d9nB0ucxYUA65viFWhfTMtkxrAHwMXk42BHhyX09J59ev_q4fVvdvH9zvb26qXrBhaxaZ6ER0lumlZVWc60Fc8ZKrUGDcpzVTnqufc8UE4PjtQFfezWYoTGs9uKcvDj2nZf0LQOu3RSwh3G0EVLGTrBWMVW3Shb6_B-6S3mJZbqiJG9bIxpT1LN7ld0EvpuXMJV9uz9fWsDLI-iXhLjA8Jdw1v2OqytxdXdxFXt5tPswwuH_sHv3eXt88QspxZgv
Cites_doi 10.1111/myc.12815
10.1111/myc.13553
10.1128/JCM.01821-18
10.2471/BLT.11.089441
10.1111/j.1365-2567.2009.03211.x
10.1093/infdis/jiab583
10.1183/09031936.06.00021705
10.1111/myc.12987
10.1016/j.jinf.2016.10.010
10.1111/j.1744-313X.2006.00616.x
10.2147/IDR.S403401
10.3390/jof3020026
10.1016/j.vaccine.2015.10.114
10.1093/cid/cix749
10.3389/fimmu.2021.788502
10.1093/infdis/jiu490
10.1111/1469-0691.12473
10.1016/S1473-3099(22)00057-3
10.1086/526500
10.1016/j.heliyon.2023.e15356
10.1186/1471-2334-12-144
10.4049/jimmunol.1501811
10.1183/13993003.00583-2015
10.1038/d41586-017-08280-8
10.1016/0041-3879(70)90015-2
10.1111/j.1744-313X.2011.01078.x
10.1016/j.ijregi.2022.11.005
10.1086/376526
10.1038/s41390-022-02055-2
10.2741/e406
10.1016/S0140-6736(07)61602-X
10.1016/S0041-3879(68)80002-9
10.1080/17476348.2016.1249853
10.3389/fimmu.2021.693055
10.1111/cea.12141
10.1080/17476348.2020.1750956
10.1515/CCLM.2007.033
10.1159/000234069
10.1136/thoraxjnl-2019-213606
10.1086/322791
10.1183/13993003.01184-2018
10.1038/s41586-023-06968-8
10.5005/ijcdas-53-3-137
10.1111/1469-0691.12643
ContentType Journal Article
Copyright 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd
2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
Copyright_xml – notice: 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd
– notice: 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
M7N
7X8
DOI 10.1111/myc.13746
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1439-0507
EndPage n/a
ExternalDocumentID 38767275
10_1111_myc_13746
MYC13746
Genre researchArticle
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1OB
1OC
29M
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
ZXP
ZZTAW
~IA
~KM
~WT
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
AEUQT
AFPWT
CGR
CUY
CVF
ECM
EIF
LATKE
NPM
WRC
WUP
M7N
7X8
ID FETCH-LOGICAL-c3136-5bae436da087a6a818830b9a688e8e7b102b6d18dc0703fb129ed2d7f9f4902d3
IEDL.DBID DR2
ISSN 0933-7407
1439-0507
IngestDate Fri Jul 11 09:57:30 EDT 2025
Mon Jul 14 10:36:57 EDT 2025
Wed Feb 19 02:13:01 EST 2025
Tue Jul 01 04:31:06 EDT 2025
Sun Jul 06 04:45:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords innate immunity
CPA
adaptive immunity
Aspergillosis
TH‐1 response
Language English
License 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3136-5bae436da087a6a818830b9a688e8e7b102b6d18dc0703fb129ed2d7f9f4902d3
Notes Naresh Kumar Chirumamilla and Kanika Arora have contributed equally and may be considered joint first authors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0850-3118
0000-0002-6505-6019
0000-0003-2547-7668
0000-0002-9097-9253
0000-0003-0410-8468
PMID 38767275
PQID 3061559349
PQPubID 2045122
PageCount 11
ParticipantIDs proquest_miscellaneous_3057072576
proquest_journals_3061559349
pubmed_primary_38767275
crossref_primary_10_1111_myc_13746
wiley_primary_10_1111_myc_13746_MYC13746
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2024
2024-05-00
2024-May
20240501
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: May 2024
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Berlin
PublicationTitle Mycoses
PublicationTitleAlternate Mycoses
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2001; 184
1968; 49
2017; 3
2019; 53
2022; 92
2013; 43
2023; 6
2006; 33
2023; 16
2019; 57
2023; 9
2024; 626
2015; 33
2011; 53
2016; 10
2003; 37
2020; 14
1970; 51
2012; 39
2018; 61
2022; 22
2018; 66
2017; 552
2012; 12
2014; 20
1986; 80
2017; 74
2023; 66
2019; 62
2021; 12
1990; 115
2007; 370
2020; 75
2015; 211
2006; 27
2010; 130
2011; 89
2013
2012; 4
2008; 197
2007; 45
2016; 47
2022; 225
2016; 196
e_1_2_7_6_1
Kurup VP (e_1_2_7_39_1) 1990; 115
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
References_xml – volume: 89
  start-page: 864
  issue: 12
  year: 2011
  end-page: 872
  article-title: Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis
  publication-title: Bull World Health Organ
– volume: 22
  start-page: 1052
  issue: 7
  year: 2022
  end-page: 1061
  article-title: Efficacy of 12‐months oral itraconazole versus 6‐months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open‐label, randomised controlled trial in India
  publication-title: Lancet Infect Dis
– volume: 57
  start-page: e01821‐18
  issue: 3
  year: 2019
  article-title: Utility of serum and Bronchoalveolar lavage fluid galactomannan in diagnosis of chronic pulmonary Aspergillosis
  publication-title: J Clin Microbiol
– volume: 225
  start-page: 1822
  issue: 10
  year: 2022
  end-page: 1831
  article-title: Defective interferon‐gamma production is common in chronic pulmonary Aspergillosis
  publication-title: J Infect Dis
– volume: 80
  start-page: 300
  issue: 3
  year: 1986
  end-page: 306
  article-title: Class‐specific antibody determination against aspergillus fumigatus by means of the enzyme‐linked immunosorbent assay. III. Comparative study: IgG, IgA, IgM ELISA titers, precipitating antibodies and IgE binding after fractionation of the antigen
  publication-title: Int Arch Allergy Appl Immunol
– volume: 115
  start-page: 298
  issue: 3
  year: 1990
  end-page: 303
  article-title: Antibody isotype responses in aspergillus‐induced diseases
  publication-title: J Lab Clin Med
– volume: 45
  start-page: 183
  issue: 2
  year: 2007
  end-page: 186
  article-title: Distinct alleles of mannose‐binding lectin (MBL) and surfactant proteins a (SP‐A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
  publication-title: Clin Chem Lab Med
– volume: 37
  start-page: S265
  issue: Suppl 3
  year: 2003
  end-page: S280
  article-title: Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review
  publication-title: Clin Infect Dis
– volume: 626
  start-page: 827
  issue: 8000
  year: 2024
  end-page: 835
  article-title: Smoking changes adaptive immunity with persistent effects
  publication-title: Nature
– volume: 66
  start-page: 299
  issue: 4
  year: 2023
  end-page: 303
  article-title: Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis
  publication-title: Mycoses
– volume: 16
  start-page: 2217
  year: 2023
  end-page: 2226
  article-title: Serum cytokine biomarkers for use in diagnosing pulmonary tuberculosis versus chronic pulmonary Aspergillosis
  publication-title: Infect Drug Resist
– volume: 61
  start-page: 770
  issue: 10
  year: 2018
  end-page: 776
  article-title: Diagnostic cut‐off of aspergillus fumigatus‐specific IgG in the diagnosis of chronic pulmonary aspergillosis
  publication-title: Mycoses
– volume: 51
  start-page: 227
  issue: 3
  year: 1970
  end-page: 245
  article-title: Aspergilloma and residual tuberculous cavities—the results of a resurvey
  publication-title: Tubercle
– volume: 62
  start-page: 1108
  issue: 12
  year: 2019
  end-page: 1115
  article-title: Efficiency of a fumigatus‐specific IgG and galactomannan testing in the diagnosis of simple aspergilloma
  publication-title: Mycoses
– volume: 12
  year: 2021
  article-title: The role of diverse immune cells in sarcoidosis
  publication-title: Front Immunol
– volume: 47
  start-page: 45
  issue: 1
  year: 2016
  end-page: 68
  article-title: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
  publication-title: Eur Respir J
– volume: 14
  start-page: 715
  issue: 7
  year: 2020
  end-page: 727
  article-title: An overview of the available treatments for chronic cavitary pulmonary aspergillosis
  publication-title: Expert Rev Respir Med
– volume: 197
  start-page: 618
  issue: 4
  year: 2008
  end-page: 621
  article-title: Polymorphisms in toll‐like receptor genes and susceptibility to pulmonary aspergillosis
  publication-title: J Infect Dis
– volume: 552
  start-page: 337
  issue: 7685
  year: 2017
  end-page: 339
  article-title: The origins of memory T cells
  publication-title: Nature
– volume: 10
  start-page: 1317
  issue: 12
  year: 2016
  end-page: 1334
  article-title: Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis
  publication-title: Expert Rev Respir Med
– volume: 211
  start-page: 651
  issue: 4
  year: 2015
  end-page: 660
  article-title: Elevated levels of the neutrophil chemoattractant pro‐platelet basic protein in macrophages from individuals with chronic and allergic aspergillosis
  publication-title: J Infect Dis
– volume: 27
  start-page: 1307
  issue: 6
  year: 2006
  end-page: 1310
  article-title: Interferon‐gamma therapy in two patients with progressive chronic pulmonary aspergillosis
  publication-title: Eur Respir J
– volume: 49
  start-page: 1
  issue: 1
  year: 1968
  end-page: 11
  article-title: Aspergillus in persistent lung cavities after tuberculosis. A report from the research committee of the British tuberculosis association
  publication-title: Tubercle
– volume: 9
  issue: 4
  year: 2023
  article-title: Role of serum procalcitonin in the diagnosis and monitoring of treatment response in treatment‐naïve subjects with chronic pulmonary aspergillosis
  publication-title: Heliyon
– volume: 43
  start-page: 850
  issue: 8
  year: 2013
  end-page: 873
  article-title: Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
  publication-title: Clin Exp Allergy
– volume: 20
  start-page: O480
  issue: 8
  year: 2014
  end-page: O488
  article-title: A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosis
  publication-title: Clin Microbiol Infect
– volume: 3
  issue: 2
  year: 2017
  article-title: Innate and adaptive immune defects in chronic pulmonary Aspergillosis
  publication-title: J Fungi (Basel)
– volume: 4
  start-page: 651
  year: 2012
  end-page: 661
  article-title: SP‐A and SP‐D in host defense against fungal infections and allergies
  publication-title: Front Biosci (Elite Ed)
– volume: 53
  start-page: 1801184
  issue: 3
  year: 2019
  article-title: Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation
  publication-title: Eur Respir J
– volume: 33
  start-page: 297
  issue: 4
  year: 2006
  end-page: 302
  article-title: Cytokine profiling of pulmonary aspergillosis
  publication-title: Int J Immunogenet
– volume: 33
  start-page: 7271
  issue: 51
  year: 2015
  end-page: 7275
  article-title: Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis
  publication-title: Vaccine
– volume: 66
  start-page: 261
  issue: 2
  year: 2018
  end-page: 267
  article-title: Pentraxin 3 gene polymorphisms and pulmonary Aspergillosis in chronic obstructive pulmonary disease patients
  publication-title: Clin Infect Dis
– volume: 6
  start-page: 7
  year: 2023
  end-page: 14
  article-title: New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB—a revised burden for India
  publication-title: IJID Reg
– volume: 20
  start-page: O960
  issue: 11
  year: 2014
  end-page: O968
  article-title: Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT
  publication-title: Clin Microbiol Infect
– volume: 75
  start-page: 513
  issue: 6
  year: 2020
  end-page: 516
  article-title: Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all‐cause hospital admission
  publication-title: Thorax
– volume: 74
  start-page: 81
  issue: 1
  year: 2017
  end-page: 88
  article-title: Pulmonary immune responses against aspergillus fumigatus are characterized by high frequencies of IL‐17 producing T‐cells
  publication-title: J Infect
– volume: 12
  year: 2021
  article-title: Tissue‐resident memory T cells in antifungal immunity
  publication-title: Front Immunol
– volume: 92
  start-page: 1535
  issue: 6
  year: 2022
  end-page: 1542
  article-title: Pediatric systemic lupus erythematosus: phagocytic defect and oxidase activity of neutrophils
  publication-title: Pediatr Res
– volume: 12
  year: 2012
  article-title: Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
  publication-title: BMC Infect Dis
– volume: 196
  start-page: 1272
  issue: 3
  year: 2016
  end-page: 1283
  article-title: Human neutrophils use different mechanisms to kill aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects
  publication-title: J Immunol
– volume: 370
  start-page: 1453
  issue: 9596
  year: 2007
  end-page: 1457
  article-title: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
  publication-title: Lancet
– volume: 130
  start-page: 46
  issue: 1
  year: 2010
  end-page: 54
  article-title: Anti‐aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
  publication-title: Immunology
– volume: 184
  start-page: 653
  issue: 5
  year: 2001
  end-page: 656
  article-title: Mannose‐binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis
  publication-title: J Infect Dis
– volume: 53
  start-page: 137
  issue: 3
  year: 2011
  end-page: 140
  article-title: Allergic bronchopulmonary aspergillosis: lessons learnt from genetics
  publication-title: Indian J Chest Dis Allied Sci
– volume: 39
  start-page: 224
  issue: 3
  year: 2012
  end-page: 232
  article-title: Mannose‐binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis
  publication-title: Int J Immunogenet
– year: 2013
– ident: e_1_2_7_3_1
  doi: 10.1111/myc.12815
– ident: e_1_2_7_6_1
  doi: 10.1111/myc.13553
– ident: e_1_2_7_17_1
  doi: 10.1128/JCM.01821-18
– ident: e_1_2_7_4_1
  doi: 10.2471/BLT.11.089441
– ident: e_1_2_7_44_1
  doi: 10.1111/j.1365-2567.2009.03211.x
– ident: e_1_2_7_27_1
  doi: 10.1093/infdis/jiab583
– ident: e_1_2_7_40_1
  doi: 10.1183/09031936.06.00021705
– ident: e_1_2_7_16_1
  doi: 10.1111/myc.12987
– ident: e_1_2_7_43_1
  doi: 10.1016/j.jinf.2016.10.010
– ident: e_1_2_7_14_1
  doi: 10.1111/j.1744-313X.2006.00616.x
– ident: e_1_2_7_32_1
  doi: 10.2147/IDR.S403401
– ident: e_1_2_7_21_1
  doi: 10.3390/jof3020026
– ident: e_1_2_7_29_1
  doi: 10.1016/j.vaccine.2015.10.114
– ident: e_1_2_7_31_1
  doi: 10.1093/cid/cix749
– ident: e_1_2_7_33_1
  doi: 10.3389/fimmu.2021.788502
– ident: e_1_2_7_12_1
  doi: 10.1093/infdis/jiu490
– ident: e_1_2_7_11_1
  doi: 10.1111/1469-0691.12473
– ident: e_1_2_7_7_1
  doi: 10.1016/S1473-3099(22)00057-3
– ident: e_1_2_7_22_1
  doi: 10.1086/526500
– ident: e_1_2_7_5_1
  doi: 10.1016/j.heliyon.2023.e15356
– ident: e_1_2_7_28_1
  doi: 10.1186/1471-2334-12-144
– ident: e_1_2_7_37_1
  doi: 10.4049/jimmunol.1501811
– ident: e_1_2_7_18_1
  doi: 10.1183/13993003.00583-2015
– ident: e_1_2_7_46_1
  doi: 10.1038/d41586-017-08280-8
– ident: e_1_2_7_9_1
  doi: 10.1016/0041-3879(70)90015-2
– ident: e_1_2_7_26_1
  doi: 10.1111/j.1744-313X.2011.01078.x
– volume: 115
  start-page: 298
  issue: 3
  year: 1990
  ident: e_1_2_7_39_1
  article-title: Antibody isotype responses in aspergillus‐induced diseases
  publication-title: J Lab Clin Med
– ident: e_1_2_7_2_1
  doi: 10.1016/j.ijregi.2022.11.005
– ident: e_1_2_7_13_1
  doi: 10.1086/376526
– ident: e_1_2_7_20_1
  doi: 10.1038/s41390-022-02055-2
– ident: e_1_2_7_30_1
  doi: 10.2741/e406
– ident: e_1_2_7_15_1
  doi: 10.1016/S0140-6736(07)61602-X
– ident: e_1_2_7_10_1
  doi: 10.1016/S0041-3879(68)80002-9
– ident: e_1_2_7_36_1
  doi: 10.1080/17476348.2016.1249853
– ident: e_1_2_7_45_1
  doi: 10.3389/fimmu.2021.693055
– ident: e_1_2_7_35_1
  doi: 10.1111/cea.12141
– ident: e_1_2_7_19_1
  doi: 10.1080/17476348.2020.1750956
– ident: e_1_2_7_24_1
  doi: 10.1515/CCLM.2007.033
– ident: e_1_2_7_38_1
  doi: 10.1159/000234069
– ident: e_1_2_7_42_1
– ident: e_1_2_7_41_1
  doi: 10.1136/thoraxjnl-2019-213606
– ident: e_1_2_7_25_1
  doi: 10.1086/322791
– ident: e_1_2_7_8_1
  doi: 10.1183/13993003.01184-2018
– ident: e_1_2_7_47_1
  doi: 10.1038/s41586-023-06968-8
– ident: e_1_2_7_34_1
  doi: 10.5005/ijcdas-53-3-137
– ident: e_1_2_7_23_1
  doi: 10.1111/1469-0691.12643
SSID ssj0017926
Score 2.3884456
Snippet Background Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with...
Post-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA...
BackgroundPost‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e13746
SubjectTerms Adaptive Immunity
Adult
Age composition
Aspergillosis
Body weight
CPA
Female
Helper cells
Humans
Immune response
Immunity, Innate
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Immunological memory
innate immunity
Leukocytes (neutrophilic)
Lung - immunology
Lymphocytes
Lymphocytes T
Male
Mannose
Memory cells
Middle Aged
Neutrophils
Neutrophils - immunology
Population studies
Prospective Studies
Pulmonary Aspergillosis - complications
Pulmonary Aspergillosis - immunology
Respiratory Burst
Risk factors
TH‐1 response
Tuberculosis
Tuberculosis, Pulmonary - complications
Tuberculosis, Pulmonary - immunology
Young Adult
Title Innate and adaptive immune responses in subjects with CPA secondary to post‐pulmonary tuberculosis lung abnormalities
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fmyc.13746
https://www.ncbi.nlm.nih.gov/pubmed/38767275
https://www.proquest.com/docview/3061559349
https://www.proquest.com/docview/3057072576
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD6UiuCLtl5jL4zigy9Zkp1LEnzari5VqIhYqCCEuQWWrsmykyD1yZ_gb_SXOGeyCVYRxLeQTJjbuXxn5sw3AM8SnVZSGB0rmrGYCc1iVQkey8rYRBjK8woDxbO34vScvbngFzvwYjgL0_NDjAtuqBnBXqOCS-V-UfLPV3qS-gqQbhtztRAQvR-po7ychavWMGCPMx-1bFmFMItn_PO6L_oDYF7Hq8HhLO7Ap6GpfZ7J5aRr1UR__Y3F8T_7sge3t0CUzHrJ2YcdW9-Fm_3VlFf34MvruvYwlMjaEGnkGq0iWeJhEks2fV6tdWRZE9cpXMpxBFd0yfzdjDiMsY1vDGkbsm5c--Pb93W38vIe3nXKbnS3atzSkZU3NUSqGoHzKnC73ofzxasP89N4e0lDrKkf9pgraRkVRiZ5JoX0_j-niSqkyHOb20x5AKOESXOj0bhUyuMLa6Ymq4qKFcnU0AewWze1fQSkkNzYXEjKmGHKaKm04drQguk0lVxE8HSYrnLdc3GUQwzjR7AMIxjB4TCR5VYdXUmTsP1KWRHBk_GzVyTcHZG1bTosw7Mkw_grgoe9AIy1UO8zPNDjETwP0_j36suzj_Pw8Pjfix7AramHSn0a5SHstpvOHnmo06pjuDE7eXmyOA6y_RMgQ_8I
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_OE9EXvz-qp0bxwZcu7eajLfhyLB57enuI3MH5ICXJpLC4psu2Rc4n_wT_Rv8Sk3RbPEUQ30qbkjaZmfx-k8kMwItEp5UUqGNFMxYzoVmsKsFjWaFJBFKeV54oLo7F_JS9OeNnO_BqOAvT54cYHW5eM4K99gruHdK_aPnncz1JXQ_iElz2Fb0DoXo_Jo9ykhaKrXnKHmeOt2zzCvk4nvHVi6vRHxDzImINS87BDfg4fGwfafJp0rVqor_-lsfxf__mJlzfYlGy3wvPLdgx9jZc6atTnt-BL4fWOiRKpEUiUa69YSRLf57EkE0fWmsasrSk6ZT35jTEO3XJ7N0-aTzNRvc1pK3Jum7aH9--r7uVE_lwr1Nmo7tV3SwbsnLWhkhlPXZehfSud-H04PXJbB5v6zTEmqZUxFxJw6hAmeSZFNJBgJwmqpAiz01uMuUwjBKY5qi9famUgxgGp5hVRcWKZIr0Huza2poHQArJ0eRCUsaQKdRSaeQaacF0mkouIng-zFe57tNxlAONcSNYhhGMYG-YyXKrkU1Jk7ADS1kRwbPxsdMlv0Eirak734ZnSeYpWAT3ewkYe6Fu2XBYj0fwMszj37svFx9m4eLhvzd9ClfnJ4uj8ujw-O0juDZ1yKmPqtyD3XbTmccO-bTqSRDwn_DoAcA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB5qRfHFezVadRUffMkhOXvJhj6VUw-t2lLEQgUh7C1w8LgJJwlSn_wJ_Y39Jd3dnASrCOJbSDbMXmZmv5mdnQF4nai0FEyrWOKMxIQpEsuS0ViU2iRMY8pLbygeHrH9E_LulJ5uwM5wF6bPDzE63LxkBH3tBbzW5S9C_u1MTVJHgF2D64Ql3LP03scxd5RjtFBrzVvscebMlnVaIR_GM_56dTP6A2FeBaxhx5nfgS9DX_tAk6-TrpUT9eO3NI7_OZi7cHuNRNFuzzr3YMPY-3Cjr0159gC-H1jrcCgSViOhRe3VIlr42yQGrfrAWtOghUVNJ70vp0HepYtmx7uo8Ua2dp1BbYXqqmkvfp7X3dIxfHjXSbNS3bJqFg1aOl2DhLQeOS9DcteHcDJ_-2m2H6-rNMQKp5jFVApDMNMi4ZlgwgEAjhOZC8a54SaTDsFIplOuldcupXQAw-ipzsq8JHky1XgLNm1lzWNAuaDacCYwIZpIrYRUmiqNc6LSVFAWwathuYq6T8ZRDEaMm8EizGAE28NCFmt5bAqchPNXTPIIXo6fnST54xFhTdX5NjRLMm-ARfCoZ4CRCnabhkN6NII3YRn_Tr44_DwLD0_-vekLuHm8Ny8-HBy9fwq3pg429SGV27DZrjrzzMGeVj4P7H0JE9AAeA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Innate+and+adaptive+immune+responses+in+subjects+with+CPA+secondary+to+post-pulmonary+tuberculosis+lung+abnormalities&rft.jtitle=Mycoses&rft.au=Chirumamilla%2C+Naresh+Kumar&rft.au=Arora%2C+Kanika&rft.au=Kaur%2C+Mandeep&rft.au=Agarwal%2C+Ritesh&rft.date=2024-05-01&rft.issn=1439-0507&rft.eissn=1439-0507&rft.volume=67&rft.issue=5&rft.spage=e13746&rft_id=info:doi/10.1111%2Fmyc.13746&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0933-7407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0933-7407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0933-7407&client=summon